{Reference Type}: Journal Article
{Title}: Current Status of Biomarkers and Molecular Diagnostic Tools for Rejection in Liver Transplantation: Light at the End of the Tunnel?
{Author}: El Sabagh A;Mohamed IB;Aloor FZ;Abdelwahab A;Hassan MM;Jalal PK;
{Journal}: J Clin Exp Hepatol
{Volume}: 13
{Issue}: 1
{Year}: Jan-Feb 2023
暂无{DOI}: 10.1016/j.jceh.2022.06.010
{Abstract}: Strategies to minimize immune-suppressive medications after liver transplantation are limited by allograft rejection. Biopsy of liver is the current standard of care in diagnosing rejection. However, it adds to physical and economic burden to the patient and has diagnostic limitations. In this review, we aim to highlight the different biomarkers to predict and diagnose acute rejection. We also aim to explore recent advances in molecular diagnostics to improve the diagnostic yield of liver biopsies.